
How Multi-Omic Testing Is Transforming Care
Venture Capital
With 250 biomarkers and a $5M raise, Kean wants to prove predictive health isn’t…
Venture Capital
With 250 biomarkers and a $5M raise, Kean wants to prove predictive health isn’t…
Venture Capital
For two decades, retailers poured billions into personalization engines and homepages. The result? Bloated…
Venture Capital
The rideshare boom reshaped urban transportation, bringing millions of riders and drivers into a…
Venture Capital
Why It Matters:Consumer interest in longevity and wellness has never been higher—with the global…
Venture Capital
For decades, radiology was the dream. One of the coveted R.O.A.D. specialties—Radiology, Ophthalmology, Anesthesiology,…
Venture Capital
As agentic AI begins to drive online discovery and decisions, Cimulate’s cofounders—an MIT professor…
Venture Capital
Why It Matters Define Ventures’ new report provides a clear framework for how enterprise…
Venture Capital
As ransomware, regulation, and geopolitical instability strain traditional cloud systems, Finland’s SpaceTime is rethinking…
Venture Capital
Flush with funding and surging demand, compounding pharmacies are attracting capital from private equity…
Venture Capital
As demand surges for semaglutide alternatives like compounded GLP-1 medications, telehealth platforms, compounding pharmacies,…